Viking Therapeutics (VKTX 0.37%) leaped onto center stage early last year when it announced promising news about a candidate addressing an area of soaring demand: weight loss. The ...
Eli Lilly’s fair value estimate has recently been raised from $891.62 to $919.33. This reflects a modest increase in the company’s intrinsic valuation amid evolving market sentiment. The upward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback